← Back to Discover
Trails Edge Capital Partners, LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $629,911,888
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- LB PHARMACEUTICALS INC · COM SHS · 50180M108 · shares: $49,429,679
- NURIX THERAPEUTICS INC · COM · 67080M103 · shares: $38,166,318
- IMMUNOCORE HLDGS PLC · ADS · 45258D105 · shares: $33,757,680
- FIRST TRACKS BIOTHERAPEUTICS · ORD SHS · 337185102 · shares: $30,461,680
- 4D MOLECULAR THERAPEUTICS IN · COM · 35104E100 · shares: $29,631,296
- BIOMARIN PHARMACEUTICAL INC · COM · 09061G101 · shares: $29,296,640
- DESIGN THERAPEUTICS INC · COM · 25056L103 · shares: $28,958,550
- XENON PHARMACEUTICALS INC · COM · 98420N105 · shares: $26,558,400
- MIRUM PHARMACEUTICALS INC · COM · 604749101 · shares: $26,143,136
- INSMED INC · COM PAR $.01 · 457669307 · shares: $24,557,891
Reported holdings
35 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 1,523,022 shares | $49,429,679 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 1,573,220 shares | $38,166,318 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 1,063,234 shares | $33,757,680 |
| FIRST TRACKS BIOTHERAPEUTICS | ORD SHS | 337185102 | — | 1,514,000 shares | $30,461,680 |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | — | 2,227,917 shares | $29,631,296 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 512,000 shares | $29,296,640 |
| DESIGN THERAPEUTICS INC | COM | 25056L103 | — | 2,001,282 shares | $28,958,550 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 440,000 shares | $26,558,400 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 223,312 shares | $26,143,136 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 230,331 shares | $24,557,891 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 288,089 shares | $24,542,302 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 1,110,000 shares | $24,264,600 |
| NEUROGENE INC | COM | 64135M105 | — | 714,885 shares | $22,483,133 |
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | — | 984,786 shares | $21,694,836 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 115,750 shares | $21,677,660 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 9,051,318 shares | $18,374,176 |
| INCYTE CORP | COM | 45337C102 | — | 155,000 shares | $17,570,800 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 891,881 shares | $16,481,961 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 750,000 shares | $14,602,500 |
| FAETH THERAPEUTICS INC | COM NEW | 81728A207 | — | 515,335 shares | $12,883,375 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 2,571,478 shares | $12,008,803 |
| OPUS GENETICS INC | COM | 67577R102 | — | 2,743,658 shares | $11,276,434 |
| SOL-GEL TECHNOLOGIES LTD | SHS NEW | M8694L137 | — | 139,445 shares | $10,338,452 |
| AURA BIOSCIENCES INC | COM | 05153U107 | — | 1,443,333 shares | $10,247,665 |
| CENTURY THERAPEUTICS INC | COM | 15673T100 | — | 4,134,969 shares | $10,130,674 |
| INVENTIVA SA | ADS | 46124U107 | — | 2,657,997 shares | $10,047,228 |
| CAMP4 THERAPEUTICS CORP | COM | 13463J101 | — | 1,932,937 shares | $8,446,935 |
| ALTIMMUNE INC | COM NEW | 02155H200 | — | 2,660,000 shares | $8,086,400 |
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | — | 1,419,000 shares | $7,875,450 |
| PROMIS NEUROSCIENCES INC | COM SHS | 74346M505 | — | 557,103 shares | $7,331,475 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 1,438,456 shares | $6,559,359 |
| FORTE BIOSCIENCES INC | COM NEW | 34962G208 | — | 273,181 shares | $5,805,097 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 500,000 shares | $5,350,000 |
| VTV THERAPEUTICS INC | CL A NEW | 918385204 | — | 85,192 shares | $3,207,479 |
| IMAGENEBIO INC | COM | 45175G207 | — | 282,004 shares | $1,663,824 |